We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRNS icon
176
Varonis Systems
VRNS
$5.25B
$5.28M 0.07%
427,212
+320,112
+299% +$3.67M
CALD
177
DELISTED
Callidus Software, Inc.
CALD
$5.25M 0.07%
217,457
-5,500
-2% -$119K
SUPN icon
178
Supernus Pharmaceuticals
SUPN
$2.68B
$5.17M 0.07%
120,000
-405,000
-77% -$14.4M
BIDU icon
179
Baidu
BIDU
$35.8B
$5.16M 0.07%
28,866
-80,311
-74% -$14.6M
CASH icon
180
Pathward Financial
CASH
$1.81B
$4.94M 0.07%
166,725
-5,574
-3% -$162K
ACAD icon
181
Acadia Pharmaceuticals
ACAD
$4.25B
$4.88M 0.07%
175,000
– –
AMGN icon
182
Amgen
AMGN
$203B
$4.74M 0.06%
27,500
+2,500
+10% +$407K
EXEL icon
183
Exelixis
EXEL
$13.9B
$4.68M 0.06%
190,000
+40,000
+27% +$846K
TWLO icon
184
Twilio
TWLO
$29.1B
$4.65M 0.06%
159,886
+74,516
+87% +$2.04M
AUY
185
DELISTED
Yamana Gold, Inc.
AUY
$4.53M 0.06%
+1,846,454
New +$4.98M
ONC
186
BeOne Medicines Ltd
ONC
$33.8B
$4.5M 0.06%
100,000
– –
EVH icon
187
Evolent Health
EVH
$475M
$4.34M 0.06%
+171,281
New +$4.12M
CRIS icon
188
Curis
CRIS
$9.53M
$4.32M 0.06%
1,144
+323
+39% +$1.35M
ZD icon
189
Ziff Davis
ZD
$1.9B
$4.25M 0.06%
57,522
+244
+0.4% +$18.2K
GG
190
DELISTED
Goldcorp Inc
GG
$3.73M 0.05%
+287,999
New +$4.03M
NSTG
191
DELISTED
NanoString Technologies, Inc.
NSTG
$3.72M 0.05%
225,000
+25,000
+13% +$441K
CASC
192
DELISTED
Cascadian Therapeutics, Inc.
CASC
$3.71M 0.05%
1,000,000
+450,000
+82% +$1.79M
EWBC icon
193
East-West Bancorp
EWBC
$17.9B
$3.66M 0.05%
62,500
– –
MAIN icon
194
Main Street Capital
MAIN
$4.97B
$3.42M 0.05%
88,800
-26,200
-23% -$1.02M
SHPG
195
DELISTED
Shire pic
SHPG
$3.31M 0.04%
20,000
+5,000
+33% +$874K
DFS
196
DELISTED
Discover Financial Services
DFS
$3.25M 0.04%
52,200
-20,300
-28% -$1.26M
DXCM icon
197
DexCom
DXCM
$27.6B
$2.93M 0.04%
160,400
– –
PCTY icon
198
Paylocity
PCTY
$6.71B
$2.92M 0.04%
64,523
-50,445
-44% -$2.2M
DERM
199
DELISTED
Dermira, Inc.
DERM
$2.91M 0.04%
100,000
– –
WDAY icon
200
Workday
WDAY
$33.4B
$2.89M 0.04%
29,779
-12,000
-29% -$1.12M
6 7
8
9 10

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.